Understanding and managing obesity-related HFpEF
10' education - July 22, 2019 - Milton Packer, MD - Dallas, TX, USAVideo navigation menu
The unmet need in recognition of HF: the typical patient with HF looks different these days 0:35
Why obesity is a problem in HFpEF 3:06
Distinction of the two phenotypes of HFpEF 11:50
Substances secreted from the adipose tissue into the heart 13:10
Mechanisms through which the adipogenic hormones might induce HF? 16:05
Educational information
This lecture by dr. Packer was part of a CME accredited symposium "Reshaping the future of heart failure management - Translating innovations to practice in HFpEF".
Faculty
Milton Packer, MD, is an internationally recognized clinical investigator in the field of heart failure. He spent most of this career in New York City, where he was the Dickinson Richards Professor and Chief of the Division of CIrculatory Physiology at Columbia University. From 2004-2015 he was Professor and Chair of the Department of Clinical Sciences at the University of Texas Southwestern Medical Center at Dallas. Dr. Packer is currently the Distinguished Scholar in Cardiovascular Science at Baylor University Medical Center, part of Baylor Scott & White Health.
Disclosures
This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenters and do not necessarily reflect the views of PACE-cme.
Funding
Funding for this educational program was provided by unrestricted educational grants from Novartis, Novo Nordisk and Pfizer.
Share this page with your colleagues and friends: